Skip to main content
VRCA $3.56 -4.30%
VRCA logo
VRCA · Verrica Pharmaceuticals Inc.
Track VRCA — free
$3.56 -0.16 (-4.30%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Market Cap
$61.16M
Shares
17.18M
Volume · Nov 13 18.68K Avg daily vol (3M) 72.22K
All webcasts

Earnings call · FY2025 Q1

Verrica Pharmaceuticals Inc. (VRCA) Q1 2025 Earnings Call

Concluded May 13, 2025
May 13, 2025
Period
FY2025 Q1
Runtime
—
Sources
2 artifacts
Revenue $3.44M -10.1% YoY
Diluted EPS -$1.03
Gross margin · derived Q4 79.6% -2.1 pp YoY
Net income -$9.74M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$3.42M +5.9% YoY
License And Collaboration Revenue Commercial Supply And Development$17,000
License and Collaboration Revenue$17,000
License and Collaboration Revenue Milestones$0
Full-screen source Call document